Close
Achema middle east
swop processing & packaging

TPI to start test runs at JCM manufacturing plant

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Onshoring of Drug Product Manufacturing to Massachusetts

Moderna is set to expand its US manufacturing capabilities through...

The Rise of Pharma 4.0: Digital Twins, AI and Predictive Manufacturing

The pharmaceutical manufacturing industry stands at a transformative inflection...

Advanced Sterile Manufacturing: Innovations Driving Aseptic Precision

Sterile pharmaceutical manufacturing represents one of the most technically...
- Advertisement -

China-based drug manufacturer Tianyin Pharmaceutical (TPI) is set to start test run at its 250-ton Jiangchuan Macrolide facility (JCM) for good manufacturing practice (GMP) certification process.
The company will conduct the test runs by the end of this month to investigate whether the plant is maintaining GMP.Additionally, the company will also verify its performance, efficiency, reliability and safety of the Azithromycin API manufacturing at JCM.Following the successful completion of the test runs the company will initiate the GMP certification process.

Latest stories

Related stories

Onshoring of Drug Product Manufacturing to Massachusetts

Moderna is set to expand its US manufacturing capabilities through...

The Rise of Pharma 4.0: Digital Twins, AI and Predictive Manufacturing

The pharmaceutical manufacturing industry stands at a transformative inflection...

Advanced Sterile Manufacturing: Innovations Driving Aseptic Precision

Sterile pharmaceutical manufacturing represents one of the most technically...

Australian Biopharma to Expand US Plasma-Derived Therapies

The Australian-based biopharma company, CSL, plans to invest almost...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »